History of the Division of Pulmonology and Critical Care Medicine
Founding of the American Thoracic Society
In 1904, William Osler and William Welch, together with Edward Livingston Trudeau, founded the forerunner of the American Thoracic Society, the National Association for the Study and Prevention of Tuberculosis.
Osler Becomes First Vice President of the American Thoracic Society
Dr. William Osler served as the first vice president of the American Thoracic Society.
Pulmonary Medicine at Johns Hopkins
Pulmonary Medicine coalesced at Johns Hopkins over 70 years ago, and our division has made seminal contributions to medical science since its inception. Lung mechanics, heart-lung interactions, airflow limitation, asthma, COPD, acute respiratory distress syndrome, pulmonary vascular disease, lung cancer, tuberculosis, and gas exchange are just a few of the areas where Johns Hopkins faculty have pioneered.
Dr. Richard Riley's Work Attracts Prominent Physicians to Johns Hopkins
Pulmonary Medicine began to evolve as a specialty in the early 1950’s with the arrival of Richard Riley, MD at Johns Hopkins and the development and application of novel techniques to study ventilation/perfusion relationships including the measurement of arterial blood gases. Because of Dr. Riley’s work in human physiology, many distinguished leaders of pulmonary medicine interested in this emerging field were attracted to Hopkins including Leon Farhi, Mary Ellen Avery, Reuben Cherniack, John Clements, Moran Campbell, Peter Macklem, Jack Howell, John Cotes, and Solbert Permutt.
Dr. Wilmot C. Ball Links Respiratory and Circulatory Physiology to Clinical Medicine
Wilmot C. Ball, Jr., MD became Director of the Division and the Pulmonary Function Laboratories and initiated an exploration of the conceptual framework that links respiratory and circulatory physiology to clinical medicine.
Division of Pulmonology Clinical Program Enjoys Significant Growth
Solbert Permutt, MD assumed the leadership of both the clinical and research programs, and inaugurated a collaborative program integrating the clinical, research, and education activities of the Pulmonory Division with programs in the now Bloomberg School of Public Health. The Division enjoyed extensive growth of the clinical program including a new intensive care unit, and a new bronchoscopy program, as well as expansion of clinical consultative and inpatient services rendered at other hospitals in the Baltimore area.
Critical Care Medicine Added to Division of Pulmonology
This trajectory was preserved by Jimmie T. Sylvester, MD who served as director. Critical Care Medicine was added to our name, reflecting the growing importance of this field. Dr. Sylvester steered the Division with initiatives in critical care medicine and specialty outpatient clinics, and expanded the basic research effort.
Pulmonary Research Expands Under Dr. Garcia's Directorship
The directorship was assumed by Joe G. N. Garcia, MD who doubled the number of faculty and grants with considerable diversity (expansion of PhDs, women and under-represented minorities). Significant growth and expansion occurred in lung transplantation, pulmonary hypertension, adult cystic fibrosis, health care outcomes, vascular biology, asthma and COPD research.
Dr. Landon King's Directorship Brings 3 Research Grants from National Institutes of Health (NIH)
Landon S. King, MD continues a tradition of excellence and commitment to diversity. Under his leadership, we became the site of three programmatic Specialized Center of Clinical Research grants from the NIH, in acute lung injury, pulmonary hypertension, and chronic obstructive lung disease, as well other programmatic and individual grants. Dr. King was appointed the Executive Vice Dean for Johns Hopkins University School of Medicine.
Dr. Jonathan Orens Appointed Director of the Division
Jonathan Orens, MD assumes leadership of the division.
Dr. Jonathan Orens Becomes Department of Medicine's Vice Chair of Business Development
Dr. Orens was appointed to the Department of Medicine Vice Chair of Business Development.
Dr. Nadia Hansel Appointed Director of the Division
Nadia Hansel, MD was appointed Director of the division. The Division looks forward to a bright future of contributions to basic, translational, and clinical science.